Effectiveness, Safety, and Predictors of Response to Botulinum Toxin Type A in Refractory Masticatory Myalgia: A Retrospective Study

Masticatory muscle pain disorders respond well to conservative therapy; however, in some patients the pain becomes refractory. Botulinum toxin type A (BoT-A) therapy has been shown to be an effective modality in the management of refractory headache disorders. Conversely, there are conflicting repor...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of oral and maxillofacial surgery 2017-11, Vol.75 (11), p.2307-2315
Hauptverfasser:	Khawaja, Shehryar N., Scrivani, Steven J., Holland, Nicole, Keith, David A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Botulinum Toxins, Type A - adverse effects Botulinum Toxins, Type A - therapeutic use Dentistry Female Forecasting Humans Male Masticatory Muscles Middle Aged Myalgia - drug therapy Neuromuscular Agents - adverse effects Neuromuscular Agents - therapeutic use Retrospective Studies Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!